Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Characterization of novel breast carcinoma–associated BA46-derived peptides in HLA-A2.1/Db-β2mtransgenic mice
Lior Carmon, Irene Bobilev-Priel, Baruch Brenner, Dimitry Bobilev, Adrian Paz, Erez Bar-Haim, Boaz Tirosh, Tirza Klein, Mati Fridkin, Francois Lemonnier, Esther Tzehoval, Lea Eisenbach
Lior Carmon, Irene Bobilev-Priel, Baruch Brenner, Dimitry Bobilev, Adrian Paz, Erez Bar-Haim, Boaz Tirosh, Tirza Klein, Mati Fridkin, Francois Lemonnier, Esther Tzehoval, Lea Eisenbach
View: Text | PDF
Article Immunology

Characterization of novel breast carcinoma–associated BA46-derived peptides in HLA-A2.1/Db-β2mtransgenic mice

  • Text
  • PDF
Abstract

Research Article

Authors

Lior Carmon, Irene Bobilev-Priel, Baruch Brenner, Dimitry Bobilev, Adrian Paz, Erez Bar-Haim, Boaz Tirosh, Tirza Klein, Mati Fridkin, Francois Lemonnier, Esther Tzehoval, Lea Eisenbach

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
BA46 expression in different cell lines and patient tumor samples detect...
BA46 expression in different cell lines and patient tumor samples detected by RT-PCR. RNA from cell lines and fresh tumor samples was extracted, and cDNA was produced as described in Methods. The cDNA served as a template in PCR amplification with BA-46–specific primers. A 383-specific band was detected by gel electrophoresis. The lanes were as follows. (a) 1-kb marker, breast carcinomas: MDA-MB-157, MDA-MB-435, MCF7; ovarian carcinomas: SKOV, MLS, OC; bladder carcinomas: T24, sample 14, sample 19, RT4; colon carcinomas: sample 1, sample 2, sample 3, sample 4, HCT. (b) 1-kb marker, GPDH3, GPDH3, breast carcinoma: MDA-MB-231.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts